Creating Protective Antibodies for an HIV Vaccine
Induction of protective antibodies for HIV vaccine development
['FUNDING_OTHER'] · DUKE UNIVERSITY · NIH-11135439
This project aims to create a vaccine that helps the body make strong antibodies to protect against HIV.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | DUKE UNIVERSITY (nih funded) |
| Locations | 1 site (DURHAM, UNITED STATES) |
| Trial ID | NIH-11135439 on ClinicalTrials.gov |
What this research studies
This project is working to design an effective HIV vaccine for global use. Researchers are using advanced technologies and immunological tools to create a vaccine that teaches the body to produce special antibodies. These antibodies come in two main types: those that can broadly neutralize the virus and those that offer protection in other ways. The goal is to overcome past challenges and accelerate the creation of a vaccine that can prevent HIV infection.
Who could benefit from this research
Good fit: This research is foundational for anyone at risk of HIV infection who could benefit from a preventative vaccine in the future.
Not a fit: Patients already living with HIV would not directly benefit from a preventative vaccine, though related research might inform treatments.
Why it matters
Potential benefit: If successful, this work could lead to a highly effective vaccine that prevents HIV infection worldwide.
How similar studies have performed: Previous years of work have clarified the path forward for a protective HIV vaccine, building on defined roadblocks and first-generation immunogens.
Where this research is happening
DURHAM, UNITED STATES
- DUKE UNIVERSITY — DURHAM, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: HAYNES, BARTON F. — DUKE UNIVERSITY
- Study coordinator: HAYNES, BARTON F.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Acquired Immune Deficiency Syndrome Virus, Acquired Immunodeficiency Syndrome Virus